Creation of a novel telomere-cutting endonuclease based on the EN domain of telomere-specific non-long terminal repeat retrotransposon, TRAS1

<p>Abstract</p> <p>Background</p> <p>The ends of chromosomes, termed telomeres consist of repetitive DNA. The telomeric sequences shorten with cell division and, when telomeres are critically abbreviated, cells stop proliferating. However, in cancer cells, by the expres...

Full description

Bibliographic Details
Main Authors: Yoshitake Kazutoshi, Aoyagi Hideyuki, Fujiwara Haruhiko
Format: Article
Language:English
Published: BMC 2010-04-01
Series:Mobile DNA
Online Access:http://www.mobilednajournal.com/content/1/1/13
id doaj-2b02b19d53324c298c5b7bbda6410b58
record_format Article
spelling doaj-2b02b19d53324c298c5b7bbda6410b582020-11-24T22:07:15ZengBMCMobile DNA1759-87532010-04-01111310.1186/1759-8753-1-13Creation of a novel telomere-cutting endonuclease based on the EN domain of telomere-specific non-long terminal repeat retrotransposon, TRAS1Yoshitake KazutoshiAoyagi HideyukiFujiwara Haruhiko<p>Abstract</p> <p>Background</p> <p>The ends of chromosomes, termed telomeres consist of repetitive DNA. The telomeric sequences shorten with cell division and, when telomeres are critically abbreviated, cells stop proliferating. However, in cancer cells, by the expression of telomerase which elongates telomeres, the cells can continue proliferating. Many approaches for telomere shortening have been pursued in the past, but to our knowledge, cutting telomeres <it>in vivo </it>has not so far been demonstrated. In addition, there is lack of information on the cellular effects of telomere shortening in human cells.</p> <p>Results</p> <p>Here, we created novel chimeric endonucleases to cut telomeres by fusing the endonuclease domain (TRAS1EN) of the silkworm's telomere specific non-long terminal repeat retrotransposon TRAS1 to the human telomere-binding protein, TRF1. An <it>in vitro </it>assay demonstrated that the TRAS1EN-TRF1 chimeric endonucleases (T-EN and EN-T) cut the human (TTAGGG)<sub>n </sub>repeats specifically. The concentration of TRAS1EN-TRF1 chimeric endonucleases necessary for the cleavage of (TTAGGG)<sub>n </sub>repeats was about 40-fold lower than that of TRAS1EN alone. When TRAS1EN-TRF1 endonucleases were introduced into human U2OS cancer cells using adenovirus vectors, the enzymes localized at telomeres of nuclei, cleaved and shortened the telomeric DNA by double-strand breaks. When human U2OS and HFL-1 fibroblast cells were infected with EN-T recombinant adenovirus, their cellular proliferation was suppressed for about 2 weeks after infection. In contrast, the TRAS1EN mutant (H258A) chimeric endonuclease fused with TRF1 (ENmut-T) did not show the suppression effect. The EN-T recombinant adenovirus induced telomere shortening in U2OS cells, activated the p53-dependent pathway and caused the senescence associated cellular responses, while the ENmut-T construct did not show such effects.</p> <p>Conclusions</p> <p>A novel TRAS1EN-TRF1 chimeric endonuclease (EN-T) cuts the human telomeric repeats (TTAGGG)<sub>n </sub>specifically <it>in vitro </it>and <it>in vivo</it>. Thus, the chimeric endonuclease which is expressed from an adenoviral vector can suppress cell proliferation of cancer cells.</p> http://www.mobilednajournal.com/content/1/1/13
collection DOAJ
language English
format Article
sources DOAJ
author Yoshitake Kazutoshi
Aoyagi Hideyuki
Fujiwara Haruhiko
spellingShingle Yoshitake Kazutoshi
Aoyagi Hideyuki
Fujiwara Haruhiko
Creation of a novel telomere-cutting endonuclease based on the EN domain of telomere-specific non-long terminal repeat retrotransposon, TRAS1
Mobile DNA
author_facet Yoshitake Kazutoshi
Aoyagi Hideyuki
Fujiwara Haruhiko
author_sort Yoshitake Kazutoshi
title Creation of a novel telomere-cutting endonuclease based on the EN domain of telomere-specific non-long terminal repeat retrotransposon, TRAS1
title_short Creation of a novel telomere-cutting endonuclease based on the EN domain of telomere-specific non-long terminal repeat retrotransposon, TRAS1
title_full Creation of a novel telomere-cutting endonuclease based on the EN domain of telomere-specific non-long terminal repeat retrotransposon, TRAS1
title_fullStr Creation of a novel telomere-cutting endonuclease based on the EN domain of telomere-specific non-long terminal repeat retrotransposon, TRAS1
title_full_unstemmed Creation of a novel telomere-cutting endonuclease based on the EN domain of telomere-specific non-long terminal repeat retrotransposon, TRAS1
title_sort creation of a novel telomere-cutting endonuclease based on the en domain of telomere-specific non-long terminal repeat retrotransposon, tras1
publisher BMC
series Mobile DNA
issn 1759-8753
publishDate 2010-04-01
description <p>Abstract</p> <p>Background</p> <p>The ends of chromosomes, termed telomeres consist of repetitive DNA. The telomeric sequences shorten with cell division and, when telomeres are critically abbreviated, cells stop proliferating. However, in cancer cells, by the expression of telomerase which elongates telomeres, the cells can continue proliferating. Many approaches for telomere shortening have been pursued in the past, but to our knowledge, cutting telomeres <it>in vivo </it>has not so far been demonstrated. In addition, there is lack of information on the cellular effects of telomere shortening in human cells.</p> <p>Results</p> <p>Here, we created novel chimeric endonucleases to cut telomeres by fusing the endonuclease domain (TRAS1EN) of the silkworm's telomere specific non-long terminal repeat retrotransposon TRAS1 to the human telomere-binding protein, TRF1. An <it>in vitro </it>assay demonstrated that the TRAS1EN-TRF1 chimeric endonucleases (T-EN and EN-T) cut the human (TTAGGG)<sub>n </sub>repeats specifically. The concentration of TRAS1EN-TRF1 chimeric endonucleases necessary for the cleavage of (TTAGGG)<sub>n </sub>repeats was about 40-fold lower than that of TRAS1EN alone. When TRAS1EN-TRF1 endonucleases were introduced into human U2OS cancer cells using adenovirus vectors, the enzymes localized at telomeres of nuclei, cleaved and shortened the telomeric DNA by double-strand breaks. When human U2OS and HFL-1 fibroblast cells were infected with EN-T recombinant adenovirus, their cellular proliferation was suppressed for about 2 weeks after infection. In contrast, the TRAS1EN mutant (H258A) chimeric endonuclease fused with TRF1 (ENmut-T) did not show the suppression effect. The EN-T recombinant adenovirus induced telomere shortening in U2OS cells, activated the p53-dependent pathway and caused the senescence associated cellular responses, while the ENmut-T construct did not show such effects.</p> <p>Conclusions</p> <p>A novel TRAS1EN-TRF1 chimeric endonuclease (EN-T) cuts the human telomeric repeats (TTAGGG)<sub>n </sub>specifically <it>in vitro </it>and <it>in vivo</it>. Thus, the chimeric endonuclease which is expressed from an adenoviral vector can suppress cell proliferation of cancer cells.</p>
url http://www.mobilednajournal.com/content/1/1/13
work_keys_str_mv AT yoshitakekazutoshi creationofanoveltelomerecuttingendonucleasebasedontheendomainoftelomerespecificnonlongterminalrepeatretrotransposontras1
AT aoyagihideyuki creationofanoveltelomerecuttingendonucleasebasedontheendomainoftelomerespecificnonlongterminalrepeatretrotransposontras1
AT fujiwaraharuhiko creationofanoveltelomerecuttingendonucleasebasedontheendomainoftelomerespecificnonlongterminalrepeatretrotransposontras1
_version_ 1725821283874111488